The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells
Open accessAbstract
Objective: Mesenchymal stem cells (MSCs) are promising candidate cells for cartilage tissue engineering. Expression of cartilage hypertrophy markers (e.g., type X collagen) by MSCs undergoing chondrogenesis raises concern for a tissue engineering application for MSCs, because hypertrophy would result in apoptosis and ossification. To analyze the biologic basis of MSC hypertrophy, we examined the response of chondrifying MSCs to culture conditions known to influence chondrocyte hypertrophy, using an array of hypertrophy‐associated markers. Methods: Human MSC pellet cultures were predifferentiated for 2 weeks in a chondrogenic medium, and hypertrophy was induced by withdrawing transforming growth factor β (TGFβ), reducing the concentration of dexamethasone, and adding thyroid hormone (T3). Cultures were characterized by histologic, immunohistochemical, and biochemical methods, and gene expression was assessed using quantitative reverse transcription–polymerase chain reaction. Results: The combination of TGFβ withdrawal, a reduction in the level of dexamethasone, and the addition of T3 was essential for hypertrophy induction. Cytomorphologic changes were accompanied by increased alkaline phosphatase activity, matrix mineralization, and changes in various markers of hypertrophy, including type X collagen, fibroblast growth factor receptors 1–3, parathyroid hormone–related protein receptor, retinoic acid receptor γ, matrix metalloproteinase 13, Indian hedgehog, osteocalcin, and the proapoptotic gene p53. However, hypertrophy was not induced uniformly throughout the pellet culture, and distinct regions of dedifferentiation were observed. Conclusion: Chondrogenically differentiating MSCs behave in a manner functionally similar to that of growth plate chondrocytes, expressing a very similar hypertrophic phenotype. Under the in vitro culture conditions used here, MSC‐derived chondrocytes underwent a differentiation program analogous to that observed during endochondral embryonic skeletal development, with the potential for terminal differentiation. This culture system is applicable for the screening of hypertrophy‐inhibitory conditions and agents that may be useful to enhance MSC performance in cartilage tissue engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Chondrogenic Differentiation of Cultured Human Mesenchymal Stem Cells from Marrow
Mackay, A. M., Beck, S. C., Murphy, J. M., Barry, F. P., Chichester, C. O., & Pittenger, M. F. (1998) · Tissue Engineering · doi:10.1089/ten.1998.4.415 · Cited by 1,301
Barry, F., Boynton, R. E., Liu, B., & Murphy, J. M. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5278 · Cited by 1,020
Li, W.-J., Tuli, R., Okafor, C., Derfoul, A., Danielson, K. G., Hall, D. J., & Tuan, R. S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.03.005 · Cited by 929
Self-citationThe Chondrogenic Potential of Human Bone-Marrow-Derived Mesenchymal Progenitor Cells*
YOO, J. U., BARTHEL, T. S., NISHIMURA, K., SOLCHAGA, L., CAPLAN, A. I., GOLDBERG, V. M., & JOHNSTONE, B. (1998) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199812000-00004 · Cited by 858
Pelttari, K., Winter, A., Steck, E., Goetzke, K., Hennig, T., Ochs, B. G., Aigner, T., & Richter, W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22136 · Cited by 809
Sekiya, I., Vuoristo, J. T., Larson, B. L., & Prockop, D. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052716199 · Cited by 648
Li, W.-J., Tuli, R., Huang, X., Laquerriere, P., & Tuan, R. S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.01.002 · Cited by 616
Self-citationTuli, R., Tuli, S., Nandi, S., Huang, X., Manner, P. A., Hozack, W. J., Danielson, K. G., Hall, D. J., & Tuan, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305312200 · Cited by 492
Self-citationEndocrine Regulation of the Growth Plate
Nilsson, O., Marino, R., De Luca, F., Phillip, M., & Baron, J. (2005) · Hormone Research in Paediatrics · doi:10.1159/000088791 · Cited by 441
Cited by
Chung, C., & Burdick, J. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.027 · Cited by 760
van der Kraan, P. M., & van den Berg, W. B. (2012) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.12.003 · Cited by 661
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
Scotti, C., Tonnarelli, B., Papadimitropoulos, A., Scherberich, A., Schaeren, S., Schauerte, A., Lopez-Rios, J., Zeller, R., Barbero, A., & Martin, I. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000302107 · Cited by 477
Chondrocyte dedifferentiation and osteoarthritis (OA)
Charlier, E., Deroyer, C., Ciregia, F., Malaise, O., Neuville, S., Plener, Z., Malaise, M., & de Seny, D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.02.036 · Cited by 460
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
Kean, T. J., Lin, P., Caplan, A. I., & Dennis, J. E. (2013) · Stem Cells International · doi:10.1155/2013/732742 · Cited by 433
Articular fibrocartilage - Why does hyaline cartilage fail to repair?
Armiento, A. R., Alini, M., & Stoddart, M. J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.015 · Cited by 408
Chondrogenic Differentiation of Mesenchymal Stem Cells: Challenges and Unfulfilled Expectations
Somoza, R. A., Welter, J. F., Correa, D., & Caplan, A. I. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0771 · Cited by 359
Bian, L., Hou, C., Tous, E., Rai, R., Mauck, R. L., & Burdick, J. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.052 · Cited by 306
Osteochondral tissue engineering: scaffolds, stem cells and applications
Nooeaid, P., Salih, V., Beier, J. P., & Boccaccini, A. R. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01571.x · Cited by 300
TGFβ signaling in cartilage development and maintenance
Wang, W., Rigueur, D., & Lyons, K. M. (2014) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.21058 · Cited by 298
TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis
van der Kraan, P. M., Blaney Davidson, E. N., Blom, A., & van den Berg, W. B. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.06.008 · Cited by 290
Diekman, B. O., Rowland, C. R., Lennon, D. P., Caplan, A. I., & Guilak, F. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0398 · Cited by 267
Damaraju, S. M., Shen, Y., Elele, E., Khusid, B., Eshghinejad, A., Li, J., Jaffe, M., & Arinzeh, T. L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.024 · Cited by 265
Rowland, C. R., Lennon, D. P., Caplan, A. I., & Guilak, F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.027 · Cited by 190
“While these findings are in contrast to the stronger chondroinductive capabilities of CDM that have been previously reported for ASCs and chondrocytes [13,16,48,49], other studies have shown that CDM can prevent MSCs from entering a hypertrophic phenotype [15] that is typically observed during chondrogenic differentia…”
ResultThompson, E. M., Matsiko, A., Farrell, E., Kelly, D. J., & O'Brien, F. J. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1918 · Cited by 147
Cheung, K., Barter, M. J., Falk, J., Proctor, C. J., Reynard, L. N., & Young, D. A. (2020) · The FASEB Journal · doi:10.1096/fj.201902061rr · Cited by 23
Metadata
- Authors
- Mueller, M. B., & Tuan, R. S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2008-04-25
- Volume
- 58
- Issue
- 5
- Pages
- 1377-1388
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2087370958
- Cited by
- 487
- References
- 39
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.